Director- Purification- Process Translation and Execution

Role: Lead and develop the Process Translation and Execution (PTE) team at Lilly's Medicines Foundry, focusing on advancing downstream bioprocessing for diverse modalities including biologics (mAbs, ADCs, ARC), peptides, and oligonucleotides. Objectives: ensure right-first-time clinical supply readiness, optimize tech transfer, and drive process innovation during the construction and startup phases of the new facility. Responsibilities: oversee technical transfer of GMP manufacturing processes, support deviation investigations, develop future process strategies, and collaborate cross-functionally with Process Development, Engineering, Quality, and Operations. Qualifications: PhD in Biological or Chemical Engineering, Biochemistry, or related; 12+ years in biologics downstream development or manufacturing, with 8+ years leading chromatography, TFF, viral inactivation, and conjugation processes. Skills: hands-on experience with purification technologies, process scale-up, cGMP compliance, and emerging modalities like mRNA or LNP. Preferred: expertise in bioconjugation, single-use systems, PAT tools, and process innovation. High-Value: biologics development, GMP manufacturing, process transfer, bioconjugation, emerging biologic modalities, global regulatory standards. WorkSetup: onsite in Indianapolis, with limited travel (~5-10%).